Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ObsEva Ord Shs OBSEF

Healthcare Biotechnology
Obseva SA is a Switzerland-based company active in the pharmaceutical and medical research sector. The Company develops oral compounds to treat women’s reproductive health conditions from conception to birth. Its pipeline includes three product candidates: Linzagolix (OBE2109), an oral gonadotropin-releasing hormone (GnRH) receptor antagonist intended for the treatment of endometriosis and... see more

Recent & Breaking News (GREY:OBSEF)

ObsEva Reports Second Quarter 2018 Financial Results and Provides Business Update

GlobeNewswire August 8, 2018

ObsEva SA to Hold Second Quarter 2018 Financial Results and Business Update Call on August 8, 2018

GlobeNewswire July 31, 2018

ObsEva Expands Executive Team Hiring a Chief Commercial Officer

GlobeNewswire July 25, 2018

ObsEva SA to start trading today on the SIX Swiss Exchange

GlobeNewswire July 13, 2018

ObsEva SA Shares to Begin Trading on SIX Swiss Exchange

GlobeNewswire July 6, 2018

ObsEva Announces Pricing of Follow-on Public Offering

GlobeNewswire June 20, 2018

ObsEva Announces Launch of Proposed Follow-on Public Offering

GlobeNewswire June 18, 2018

ObsEva SA Achieves Primary and Secondary Endpoints for EDELWEISS Phase 2b Clinical Trial of Linzagolix (OBE2109) in Women with Endometriosis

GlobeNewswire June 18, 2018

ObsEva SA to Hold Investor Call to Announce Topline Results of the EDELWEISS Phase 2b Clinical Trial of Linzagolix (OBE2109) in Women with Endometriosis-Associated Pain on Monday June 18, 2018

GlobeNewswire June 15, 2018

New Research: Key Drivers of Growth for ObsEva SA, Gran Tierra Energy, Novo Nordisk A/S, HudBay Minerals, Tecnoglass, and Endeavour Silver — Factors of Influence, Major Initiatives and Sustained Production

GlobeNewswire June 7, 2018

ObsEva SA to Seek SIX Share Listing

GlobeNewswire June 1, 2018

ObsEva SA to Participate in Jefferies Global Healthcare Conference June 5-8, 2018

GlobeNewswire May 31, 2018

ObsEva Reports First Quarter 2018 Financial Results and Provides Business Update

GlobeNewswire May 16, 2018

Consolidated Research: 2018 Summary Expectations for Care, Unilever, CECO Environmental, Carter's, ObsEva SA, and ViewRay — Fundamental Analysis, Key Performance Indications

GlobeNewswire May 14, 2018

ObsEva SA to Hold First Quarter 2018 Financial Results and Business Update Call on May 16, 2018

GlobeNewswire May 8, 2018

ObsEva SA to Host Key Opinion Leader Meeting on In Vitro Fertilization (IVF) April 26, 2018 in New York City

GlobeNewswire April 16, 2018

ObsEva SA to Participate in the H.C. Wainwright Annual Global Life Sciences Conference April 8-10, 2018

GlobeNewswire March 26, 2018

ObsEva Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Business Update

GlobeNewswire March 9, 2018

ObsEva SA to Hold Fourth Quarter and Year-end 2017 Financial Results and Business Update Call on March 9, 2018

GlobeNewswire March 2, 2018

ObsEva Announces Presentations Related to its Pre-term labor (PTL) Development Program at SRI 2018 Annual Meeting

GlobeNewswire March 1, 2018